DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION

Background: Donor natural killer (NK) cell alloreactivity in umbilical cord bone marrow transplantation (UCBT) can lead to leukemic relapse. However, NK cell function is calibrated by interaction with human leukocyte antigens (HLAs). This study aimed to investigate graft-resistant leukemia after tra...

Full description

Saved in:
Bibliographic Details
Main Authors: xinchen fang, Zimin Sun, Huilan Liu, Xiang Wan, Wen Yao, Kaidi Song, Baolin Tang, Xiaoyu zhu, Jun Peng
Format: Article
Language:English
Published: PAGEPress Publications 2021-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/4363
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846095456271073280
author xinchen fang
Zimin Sun
Huilan Liu
Xiang Wan
Wen Yao
Kaidi Song
Kaidi Song
Baolin Tang
Xiaoyu zhu
Jun Peng
author_facet xinchen fang
Zimin Sun
Huilan Liu
Xiang Wan
Wen Yao
Kaidi Song
Kaidi Song
Baolin Tang
Xiaoyu zhu
Jun Peng
author_sort xinchen fang
collection DOAJ
description Background: Donor natural killer (NK) cell alloreactivity in umbilical cord bone marrow transplantation (UCBT) can lead to leukemic relapse. However, NK cell function is calibrated by interaction with human leukocyte antigens (HLAs). This study aimed to investigate graft-resistant leukemia after transplantation and compared specific genotypes of killer immunoglobulin-like receptors (KIRs) in donors and human leukocyte antigen ligands in patients. Methods: We retrospectively analyzed 232 patients with acute leukemia from a single center. Patients had undergone UCBT with myeloablative conditioning and without anti-thymocyte globulin. We identified the KIR genotypes of cord blood donors using polymerase chain reaction with sequence-specific primers. All of the donors contained KIR3DL1. Results: The patients were divided into three groups according to the HLA-B locus. The donor KIR3DL1 and recipient HLA-Bw4-80I combination was predictive of being highly educated, and was associated with a lower relapse (P = 0.006) and better overall survival (probability of relapse = 0.13, P < 0.001) than the uneducated group. We found no significant increase in the incidence of acute or chronic graft-versus-host disease. Conclusions: Our data suggest that the donor KIR3DL1/receptor and HLA-Bw4-80I combination in UCBT results in stronger graft-versus-leukemia effects and improved outcomes in patients with acute leukemia.
format Article
id doaj-art-2569576d7e904eb883a6a66b482e1cdd
institution Kabale University
issn 2035-3006
language English
publishDate 2021-01-01
publisher PAGEPress Publications
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj-art-2569576d7e904eb883a6a66b482e1cdd2025-01-02T10:37:18ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062021-01-0113110.4084/mjhid.2021.005DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETIONxinchen fang0Zimin SunHuilan LiuXiang WanWen YaoKaidi SongKaidi SongBaolin TangXiaoyu zhuJun Penga:1:{s:5:"en_US";s:68:"Department of Hematology, Qilu Hospital, Cheeloo College of Medicine";}Background: Donor natural killer (NK) cell alloreactivity in umbilical cord bone marrow transplantation (UCBT) can lead to leukemic relapse. However, NK cell function is calibrated by interaction with human leukocyte antigens (HLAs). This study aimed to investigate graft-resistant leukemia after transplantation and compared specific genotypes of killer immunoglobulin-like receptors (KIRs) in donors and human leukocyte antigen ligands in patients. Methods: We retrospectively analyzed 232 patients with acute leukemia from a single center. Patients had undergone UCBT with myeloablative conditioning and without anti-thymocyte globulin. We identified the KIR genotypes of cord blood donors using polymerase chain reaction with sequence-specific primers. All of the donors contained KIR3DL1. Results: The patients were divided into three groups according to the HLA-B locus. The donor KIR3DL1 and recipient HLA-Bw4-80I combination was predictive of being highly educated, and was associated with a lower relapse (P = 0.006) and better overall survival (probability of relapse = 0.13, P < 0.001) than the uneducated group. We found no significant increase in the incidence of acute or chronic graft-versus-host disease. Conclusions: Our data suggest that the donor KIR3DL1/receptor and HLA-Bw4-80I combination in UCBT results in stronger graft-versus-leukemia effects and improved outcomes in patients with acute leukemia.http://www.mjhid.org/index.php/mjhid/article/view/4363acute myeloid leukemia, natural killer cells, killer immunoglobulin-like receptors, umbilical cord blood transplantation,acute lymphocytic leukemia
spellingShingle xinchen fang
Zimin Sun
Huilan Liu
Xiang Wan
Wen Yao
Kaidi Song
Kaidi Song
Baolin Tang
Xiaoyu zhu
Jun Peng
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
Mediterranean Journal of Hematology and Infectious Diseases
acute myeloid leukemia, natural killer cells, killer immunoglobulin-like receptors, umbilical cord blood transplantation,acute lymphocytic leukemia
title DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
title_full DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
title_fullStr DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
title_full_unstemmed DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
title_short DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
title_sort donor kir3dl1 receptor hla bw4 80i combination reduces acute leukemia relapse after umbilical cord blood transplantation without in vitro t cell depletion
topic acute myeloid leukemia, natural killer cells, killer immunoglobulin-like receptors, umbilical cord blood transplantation,acute lymphocytic leukemia
url http://www.mjhid.org/index.php/mjhid/article/view/4363
work_keys_str_mv AT xinchenfang donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT ziminsun donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT huilanliu donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT xiangwan donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT wenyao donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT kaidisong donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT kaidisong donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT baolintang donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT xiaoyuzhu donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion
AT junpeng donorkir3dl1receptorhlabw480icombinationreducesacuteleukemiarelapseafterumbilicalcordbloodtransplantationwithoutinvitrotcelldepletion